Company Shenyang Xingqi Pharmaceutical Co.,Ltd.

300573

CNE100002DV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2025-12-09			5-day change	1st Jan Change
73.25 ^CNY	+0.22%		+0.78%	+46.96%

Dec. 08	Xingqi Pharmaceutical's 39 Products Stay in China's Insurance Drug Catalogue	MT
Oct. 28	Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

Business description: Shenyang Xingqi Pharmaceutical Co.,Ltd.

SHENYANG XINGQI PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of ophthalmic drugs. The Companyâs main products are ophthalmic prescription drugs, including corneal repairing drugs, anti-bacteria drugs, artificial tears, anti-inflammation drugs, anti-allergic drugs, as well as anti-hyperemia & fatigue relief drugs and others. The Company mainly distributes its products within domestic market.

Number of employees: 2,426

Sales by Activity: Shenyang Xingqi Pharmaceutical Co.,Ltd.

Fiscal Period: December	2020	2021	2022	2023	2024
Pharmaceutical Manufacturing	546M	707M	821M	1.09B	1.79B
Medical Service	138M	317M	406M	351M	133M
Unallocated Other Operations	5.46M	3.81M	23.2M	27.86M	19.49M

See all business segments

Geographical breakdown of sales: Shenyang Xingqi Pharmaceutical Co.,Ltd.

Fiscal Period: December	2020	2021	2022	2023	2024
China	689M	1.03B	1.25B	1.47B	1.94B

See all geographic segments

Executive Committee: Shenyang Xingqi Pharmaceutical Co.,Ltd.

Manager	Title	Age	Since
E Gao CEO	Chief Executive Officer	51	2022-07-17
Ya Nan Cheng DFI	Director of Finance/CFO	51	2011-11-11
Chun Hua Li ADM	Chief Administrative Officer	48	2022-02-15
Qiang Yang CTO	Chief Tech/Sci/R&D Officer	41	2022-07-17
Shao Yao Zhang SEC	Corporate Secretary	55	2011-11-11

See SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. governance

Composition of the Board of Directors: Shenyang Xingqi Pharmaceutical Co.,Ltd.

Director	Title	Age	Since
Xiao Yan Kong BRD	Director/Board Member	52	2024-01-04
Ji Dong Liu CHM	Chairman	68	2000-07-04
E Gao BRD	Director/Board Member	51	2011-11-11
Shao Yao Zhang BRD	Director/Board Member	55	2015-01-14
Ya Nan Cheng BRD	Director/Board Member	51	2018-01-10
Qiang Yang BRD	Director/Board Member	41	2017-05-21
Chun Hua Li BRD	Director/Board Member	48	2007-12-31
Xiao Bin Dai BRD	Director/Board Member	68	2021-01-13
Xiao Yu Qu CHM	Chairman	38	2024-01-04

Composition of the Board of Directors

Shareholders: Shenyang Xingqi Pharmaceutical Co.,Ltd.

Name	Equities	%	Valuation
China Southern Asset Management Co., Ltd. 1.486 %	2,800,771	1.486 %	28 M ¥
Franklin Templeton Sealand Fund Management Co., Ltd. 0.687 %	1,294,617	0.687 %	13 M ¥
Ji Dong Liu 0.4077 %	768,320	0.4077 %	8 M ¥
China Merchants Fund Management Co., Ltd. 0.3906 %	736,012	0.3906 %	7 M ¥
Golden Trust Sinopac Fund Management Co., Ltd. 0.3673 %	692,140	0.3673 %	7 M ¥

Name	Equities	%	Valuation
Ji Dong Liu 3.8 %	1,536,640	3.8 %	16 M ¥

List of SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. shareholders

Company details: Shenyang Xingqi Pharmaceutical Co.,Ltd.

Shenyang Xingqi Pharmaceutical Co., Ltd.

30/F, Building B, Enterprise Plaza

110016, Shenyang

http://www.sinqi.com

address Shenyang Xingqi Pharmaceutical Co.,Ltd.(300573)

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+0.22%	+0.78%	+20.85%	+41.00%	2.55B
MERCK KGAA	-1.01%	+1.11%	-16.69%	-34.42%	60.16B
KYOWA KIRIN CO., LTD.	-0.40%	-4.62%	+2.12%	-18.24%	8.46B
HALOZYME THERAPEUTICS, INC.	-0.64%	-5.73%	+27.86%	+10.19%	7.39B
SK BIOPHARMACEUTICALS CO., LTD.	+1.35%	-2.03%	+32.71%	+88.95%	7.11B
YUHAN CORPORATION	+0.34%	-4.43%	+1.39%	+115.14%	5.9B
INDIVIOR PLC	+0.08%	+7.88%	+220.35%	+66.73%	4.57B
BETTA PHARMACEUTICALS CO., LTD.	-0.06%	-1.93%	-16.15%	-4.48%	2.87B
SUPERNUS PHARMACEUTICALS, INC.	-0.27%	+6.48%	+28.08%	+33.35%	2.7B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	-0.78%	-1.16%	-16.94%	+4.08%	1.95B
Average	-0.11%	+0.55%	+28.36%	+30.23%	10.37B
Weighted average by Cap.	-0.57%	+0.88%	+4.99%	-3.30%